| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 15.354 | 30.907 | 7.484 | 20.140 | 29.867 | 35.457 |
| Total Income - EUR | 0 | 9.387 | 3 | 0 | 109.030 | 107.512 | 45.676 | 95.890 | 107.704 | 76.508 |
| Total Expenses - EUR | 0 | 12.194 | 2.298 | 10.711 | 147.895 | 131.750 | 123.587 | 203.150 | 224.506 | 204.816 |
| Gross Profit/Loss - EUR | 0 | -2.807 | -2.295 | -10.711 | -38.865 | -24.238 | -77.911 | -107.260 | -116.802 | -128.308 |
| Net Profit/Loss - EUR | 0 | -2.807 | -2.295 | -10.711 | -38.865 | -24.238 | -77.911 | -107.260 | -116.802 | -128.308 |
| Employees | 0 | 0 | 0 | 1 | 4 | 4 | 4 | 5 | 5 | 5 |
Check the financial reports for the company - Bio Nucet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 258 | 144.414 | 141.970 | 184.792 | 640.841 | 915.490 | 956.965 | 864.877 | 861.455 | 824.722 |
| Current Assets | 85.300 | 11.483 | 8.858 | 770.042 | 537.629 | 369.289 | 51.375 | 76.515 | 30.685 | 28.084 |
| Inventories | 0 | 0 | 0 | 65.242 | 71.695 | 1.860 | 5.544 | 47.229 | 15.381 | 5.517 |
| Receivables | 78.712 | 917 | 1.032 | 613.132 | 407.647 | 360.246 | 3.396 | 8.912 | 8.564 | 8.914 |
| Cash | 6.588 | 10.566 | 7.826 | 91.668 | 58.287 | 7.183 | 42.436 | 20.374 | 6.740 | 13.653 |
| Shareholders Funds | 225 | -2.584 | -4.835 | -15.414 | -53.971 | -77.186 | -153.385 | -261.121 | -358.034 | -484.341 |
| Social Capital | 225 | 223 | 219 | 258 | 263 | 258 | 253 | 253 | 253 | 251 |
| Debts | 85.333 | 158.481 | 155.664 | 369.691 | 644.198 | 796.723 | 657.041 | 732.391 | 817.578 | 937.835 |
| Income in Advance | 0 | 0 | 0 | 600.582 | 588.243 | 565.241 | 505.608 | 470.412 | 432.882 | 399.786 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Bio Nucet Srl